| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |